| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |